Annual CFF
$484.30M$466.48M+2,617.76%
Summary
- Current Value
- As of today, DNLI annual cash from financing is $484.30M, up +2617.76% on
- Historical Performance
- DNLI annual cash from financing is up +2403.12% over the past 3 years, and up +7723.97% over the past 5 years
- All-Time High Comparison
- DNLI annual cash from financing is currently -23.70% below its historical high of $634.75M set on
- 3-Year Low Comparison
- DNLI annual cash from financing is +2617.76% above its 3-year low of $17.82M reached on
- Sector Comparison
- DNLI annual cash from financing is higher than 96.53% of companies in Healthcare sector
Cash From Financing Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash From Financing | $484.30M | +2617.8% | +2403.1% | +7724.0% | +891.3% | |
| Quarterly Cash From Financing | -$778.00K | +95.8% | -115.1% | -100.2% | – | |
| TTM Cash From Financing | -$7.09M | -101.4% | -143.8% | -101.1% | – | |
| Price | $16.95 | -20.0% | -41.3% | -77.1% | – | |
| Annual Cash From Operations | -$347.69M | +2.9% | -64.5% | -129.4% | -2209.9% | |
| Annual Cash From Investing | -$88.76M | -135.6% | -310.4% | -160.1% | -2798.6% | |
| Annual Dividends Paid | $0.00 | 0.0% | 0.0% | 0.0% | 0.0% | |
| Annual Total Debt | $54.32M | +4.0% | -15.1% | -25.1% | +100.0% | |
| Shares Outstanding | 156.16M | +8.3% | +14.8% | +29.6% | – |
Cash From Financing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $484.30M | at high | |
| 5Y | $634.75M | N/A | -23.7% |
| All | $634.75M | -23.7% |
Cash From Financing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $17.82M | +2617.8% | |
| 5Y | $17.82M | +2617.8% | |
| All | $6.19M | +7724.0% |
Cash From Financing History
| Year | Value | Change |
|---|---|---|
| $484.30M | +2,617.8% | |
| $17.82M | -94.3% | |
| $310.67M | +1,505.7% | |
| $19.35M | -97.0% | |
| $634.75M | >+9,900.0% |
| Year | Value | Change |
|---|---|---|
| $6.19M | -93.6% | |
| $97.02M | -67.3% | |
| $296.32M | -1.4% | |
| $300.48M | +515.0% | |
| $48.85M | - |
FAQ
What is the current annual cash from financing of DNLI?
As of today, DNLI annual cash from financing is $484.30M
What is 1-year change in DNLI annual cash from financing?
DNLI annual cash from financing is up +2617.76% year-over-year
What is 3-year change in DNLI annual cash from financing?
DNLI annual cash from financing is up +2403.12% over the past 3 years
How far is DNLI annual cash from financing from its all-time high?
DNLI annual cash from financing is currently -23.70% below its historical high of $634.75M set on December 31, 2020
How does DNLI annual cash from financing rank versus sector peers?
DNLI annual cash from financing is higher than 96.53% of companies in Healthcare sector
When is DNLI next annual earnings release?
The next annual earnings release for DNLI is on
Quarterly CFF
-$778.00K$2.40M-147.94%
Summary
- Current Value
- As of today, DNLI quarterly cash from financing is -$778.00K, down -147.94% on
- Historical Performance
- DNLI quarterly cash from financing is up +95.81% year-over-year, and down -115.10% over the past 3 years
- All-Time High Comparison
- DNLI quarterly cash from financing is currently -100.16% below its historical high of $500.28M set on
- 3-Year Low Comparison
- DNLI quarterly cash from financing is +95.81% above its 3-year low of -$18.56M reached on
- Sector Comparison
- DNLI quarterly cash from financing is higher than 23.01% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash From Financing | -$778.00K | -147.9% | +95.8% | -115.1% | -100.2% | |
| Annual Cash From Financing | $484.30M | – | +2617.8% | +2403.1% | +7724.0% | |
| TTM Cash From Financing | -$7.09M | +71.5% | -101.4% | -143.8% | -101.1% | |
| Price | $16.95 | +13.8% | -20.0% | -41.3% | -77.1% | |
| Quarterly Cash From Operations | -$107.30M | -42.5% | -81.4% | -88.1% | -10000.0% | |
| Quarterly Cash From Investing | $57.83M | -63.4% | -38.3% | +275.1% | +127.3% | |
| Quarterly Dividends Paid | $0.00 | 0.0% | 0.0% | 0.0% | 0.0% | |
| Quarterly Total Debt | $44.40M | -4.6% | -15.4% | -28.4% | -36.5% | |
| Shares Outstanding | 156.16M | – | +8.3% | +14.8% | +29.6% |
Quarterly Cash From Financing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.62M | -147.9% | |
| 3Y | $500.28M | -100.2% | |
| 5Y | $500.28M | -100.2% | |
| All | $500.28M | -100.2% |
Quarterly Cash From Financing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$4.17M | N/A | +81.3% |
| 3Y | -$18.56M | +95.8% | |
| 5Y | -$18.56M | +95.8% | |
| All | -$18.56M | +95.8% |
Quarterly Cash From Financing History
FAQ
What is the current quarterly cash from financing of DNLI?
As of today, DNLI quarterly cash from financing is -$778.00K
What is DNLI quarterly cash from financing most recent change?
DNLI quarterly cash from financing was down -147.94% on September 30, 2025
What is 1-year change in DNLI quarterly cash from financing?
DNLI quarterly cash from financing is up +95.81% year-over-year
How far is DNLI quarterly cash from financing from its all-time high?
DNLI quarterly cash from financing is currently -100.16% below its historical high of $500.28M set on March 31, 2024
How does DNLI quarterly cash from financing rank versus sector peers?
DNLI quarterly cash from financing is higher than 23.01% of companies in Healthcare sector
When is DNLI next earnings release?
The next earnings release for DNLI is on
TTM CFF
-$7.09M$17.78M+71.51%
Summary
- Current Value
- As of today, DNLI TTM cash from financing is -$7.09M, up +71.51% on
- Historical Performance
- DNLI TTM cash from financing is down -101.44% year-over-year, and down -143.77% over the past 3 years
- All-Time High Comparison
- DNLI TTM cash from financing is currently -101.12% below its historical high of $634.75M set on
- 3-Year Low Comparison
- DNLI TTM cash from financing is +71.51% above its 3-year low of -$24.87M reached on
- Sector Comparison
- DNLI TTM cash from financing is higher than 20.74% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM Cash From Financing | -$7.09M | +71.5% | -101.4% | -143.8% | -101.1% | |
| Annual Cash From Financing | $484.30M | – | +2617.8% | +2403.1% | +7724.0% | |
| Quarterly Cash From Financing | -$778.00K | -147.9% | +95.8% | -115.1% | -100.2% | |
| Price | $16.95 | +13.8% | -20.0% | -41.3% | -77.1% | |
| TTM Cash From Operations | -$397.78M | -13.8% | -9.7% | -67.5% | -173.6% | |
| TTM Cash From Investing | $406.72M | -8.1% | +316.4% | +845.2% | +290.5% | |
| TTM Dividends Paid | $0.00 | 0.0% | 0.0% | 0.0% | 0.0% | |
| Quarterly Total Debt | $44.40M | -4.6% | -15.4% | -28.4% | -36.5% | |
| Shares Outstanding | 156.16M | – | +8.3% | +14.8% | +29.6% |
TTM Cash From Financing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $484.30M | N/A | -101.5% |
| 3Y | $516.49M | -101.4% | |
| 5Y | $634.75M | N/A | -101.1% |
| All | $634.75M | -101.1% |
TTM Cash From Financing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$24.87M | +71.5% | |
| 3Y | -$24.87M | +71.5% | |
| 5Y | -$24.87M | +71.5% | |
| All | -$24.87M | +71.5% |
TTM Cash From Financing History
FAQ
What is the current TTM cash from financing of DNLI?
As of today, DNLI TTM cash from financing is -$7.09M
What is DNLI TTM cash from financing most recent change?
DNLI TTM cash from financing was up +71.51% on September 30, 2025
What is 1-year change in DNLI TTM cash from financing?
DNLI TTM cash from financing is down -101.44% year-over-year
How far is DNLI TTM cash from financing from its all-time high?
DNLI TTM cash from financing is currently -101.12% below its historical high of $634.75M set on December 31, 2020
How does DNLI TTM cash from financing rank versus sector peers?
DNLI TTM cash from financing is higher than 20.74% of companies in Healthcare sector
When is DNLI next earnings release?
The next earnings release for DNLI is on
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
Data Sources & References
- DNLI Official Website www.denalitherapeutics.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1714899/000171489925000193/0001714899-25-000193-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1714899/000171489925000066/0001714899-25-000066-index.htm
- DNLI Profile on Yahoo Finance finance.yahoo.com/quote/DNLI
- DNLI Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/dnli